Meanwhile, the current data support earlier reports demonstrating the therapeutic sensitivity of chemotherapy-induced neuropathy to S1R antagonism (Aley and Levine, 2002; Gris et al., 2016). The gene discussed is TMBIM4; the disease is neuropathy.